{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:00:53Z","timestamp":1783634453298,"version":"3.55.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Familial hyperparathyroid syndromes involving mutations of HRPT2 (also CDC73), a tumor suppressor, are important to identify because the relatively high incidence of parathyroid malignancy associated with such mutations warrants a specific surveillance strategy. However, there is a dearth of reports describing experience with surveillance and early detection informed by genetic insight into this disorder.<\/jats:p>\n               <jats:p>Introduction: Familial isolated hyperparathyroidism (FIHP) is a rare cause of parathyroid (PT) tumors without other neoplasms or endocrinopathies. Germline mutations in CASR, MEN1, and rarely, HRPT2 have been identified in kindreds with FIHP. HRPT2 mutations may be enriched in FIHP families with PT carcinoma, underscoring the importance of identifying causative mutations.<\/jats:p>\n               <jats:p>Materials and Methods: A 13-year-old boy, whose father had died of PT carcinoma, developed primary hyperparathyroidism. A left superior PT mass was identified by ultrasonography and removed surgically. Aggressive histological features of the boy's tumor included fibrous trabeculae, mitoses, and microscopic capsular infiltration. Two years later, under close biochemical surveillance, primary hyperparathyroidism recurred 5 months after documentation of normocalcemia and normal parathyroid status. Ultrasound and MRI identified a newly enlarged right superior PT gland but indicated no recurrent disease in the left neck. Histologic features typical of a benign adenoma were evident after surgical extirpation of the gland.<\/jats:p>\n               <jats:p>Results: Leukocyte DNA analysis revealed a frameshift mutation in exon 2 of HRPT2. The initial tumor manifested the expected germline HRPT2 mutation, plus a distinct somatic frameshift mutation, consistent with the Knudson \u201ctwo hit\u201d concept of biallelic inactivation of a classic tumor suppressor gene. Genetic screening of the patient's 7 asymptomatic and previously normocalcemic siblings revealed three with the same germline HRPT2 mutation. One of the siblings newly identified as mutation-positive was noted to be hypercalcemic at the time of the genetic screening. He was found to have a PT adenoma with aggressive features. Two of the five children of another mutation-positive sibling also carry the same HRPT2 mutation.<\/jats:p>\n               <jats:p>Conclusions: Despite the reported rarity of HRPT2 mutations in FIHP, a personal or family history of PT carcinoma in FIHP mandates serious consideration of germline HRPT2 mutation status. This information can be used in diagnostic and management considerations, leading to early detection and removal of potentially malignant parathyroid tumors.<\/jats:p>","DOI":"10.1359\/jbmr.060702","type":"journal-article","created":{"date-parts":[[2006,9,22]],"date-time":"2006-09-22T16:14:14Z","timestamp":1158941654000},"page":"1666-1671","source":"Crossref","is-referenced-by-count":71,"title":["Surveillance for Early Detection of Aggressive Parathyroid Disease: Carcinoma and Atypical Adenoma in Familial Isolated Hyperparathyroidism Associated With a Germline <i>HRPT2<\/i> Mutation"],"prefix":"10.1093","volume":"21","author":[{"given":"Thomas G","family":"Kelly","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha M","family":"Shattuck","sequence":"additional","affiliation":[{"name":"Center for Molecular Medicine and Division of Endocrinology and Metabolism, University of Connecticut School of Medicine, Farmington, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Reyes-Mugica","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA"},{"name":"Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew F","family":"Stewart","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (Endocrinology), University of Pittsburgh, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F","family":"Simonds","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Udelsman","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Arnold","sequence":"additional","affiliation":[{"name":"Center for Molecular Medicine and Division of Endocrinology and Metabolism, University of Connecticut School of Medicine, Farmington, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas O","family":"Carpenter","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,12,4]]},"reference":[{"issue":"S2","key":"2024013021125003600_bib1","first-page":"N18","article-title":"Epidemiology of primary hyperparathyroidism in Europe","volume":"17","author":"Adami","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"S2","key":"2024013021125003600_bib2","first-page":"N37","article-title":"Hyperparathyroidism in hereditary syndromes: Special expressions and special managements","volume":"17","author":"Marx","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2024013021125003600_bib3","first-page":"1006","article-title":"Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: A clinically and genetically distinct syndrome","volume":"108","author":"Jackson","year":"1990","journal-title":"Surgery"},{"key":"2024013021125003600_bib4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1365-2265.1999.00633.x","article-title":"Genetic studies of a family with hereditary hyperparathyroidism-jaw tumor syndrome","volume":"50","author":"Wassif","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024013021125003600_bib5","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0030-4220(71)90347-1","article-title":"Jaw lesions in familial hyperparathyroidism","volume":"31","author":"Kennet","year":"1971","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"2024013021125003600_bib6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0030-4220(85)90239-7","article-title":"Ossifying fibroma: A clinicopathologic study of 64 cases","volume":"60","author":"Eversole","year":"1985","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"2024013021125003600_bib7","first-page":"944","article-title":"Hereditary hyperparathyroidism-jaw tumor syndrome: The endocrine tumor gene HRPT2 maps to chromosome 1q21-q31","volume":"56","author":"Szabo","year":"1995","journal-title":"Am J Hum Genet"},{"key":"2024013021125003600_bib8","first-page":"4204","article-title":"Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: Linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas","volume":"81","author":"Teh","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013021125003600_bib9","first-page":"1449","article-title":"A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome","volume":"85","author":"Haven","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013021125003600_bib10","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","article-title":"HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome","volume":"32","author":"Carpten","year":"2002","journal-title":"Nat Genet"},{"key":"2024013021125003600_bib11","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/MCB.25.2.612-620.2005","article-title":"The parafibromin tumor suppressor protein is part of a human Paf1 complex","volume":"25","author":"Rozenblatt-Rosen","year":"2005","journal-title":"Mol Cell Biol"},{"key":"2024013021125003600_bib12","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.onc.1208274","article-title":"Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1\/PRAD1 expression","volume":"24","author":"Woodard","year":"2005","journal-title":"Oncogene"},{"key":"2024013021125003600_bib13","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/00000658-193612000-00002","article-title":"Hyperparathyroidism in siblings","volume":"104","author":"Goldman","year":"1936","journal-title":"Ann Surg"},{"key":"2024013021125003600_bib14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.7326\/0003-4819-84-1-36","article-title":"Familial hyperparathyroidism: Description of a large kindred and a review of the literature","volume":"84","author":"Goldsmith","year":"1976","journal-title":"Ann Intern Med"},{"key":"2024013021125003600_bib15","first-page":"2114","article-title":"Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21\u201332 in a subset of families","volume":"83","author":"Teh","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013021125003600_bib16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2265.2002.01502.x","article-title":"Genetic analysis of the MEN1 gene and HRPT2 locus in two Italian kindreds with familial isolated hyperparathyroidism","volume":"56","author":"Cetani","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024013021125003600_bib17","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.1136\/jmg.2003.012369","article-title":"Germline and de novo mutations in the HRPT2 tumor supressor gene in familial isolated hyperparathyroidism","volume":"41","author":"Villablanca","year":"2004","journal-title":"J Med Genet"},{"key":"2024013021125003600_bib18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1210\/jc.2003-030675","article-title":"Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome","volume":"89","author":"Simonds","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013021125003600_bib19","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJM200012213432508","article-title":"Hyperparathyroid and hypoparathyroid disorders","volume":"343","author":"Marx","year":"2000","journal-title":"N Engl J Med"},{"key":"2024013021125003600_bib20","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","article-title":"Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma","volume":"349","author":"Shattuck","year":"2003","journal-title":"N Engl J Med"},{"key":"2024013021125003600_bib21","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1210\/jc.2004-0294","article-title":"Genetic analysis of the HRPT2 gene in primary hyperparathyroidism: Germline and somatic mutations in alterations in familial and sporadic parathyroid tumors","volume":"89","author":"Cetani","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013021125003600_bib22","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jmg.40.9.657","article-title":"HRPT2 mutations are associated with malignancy in sporadic parathyroid carcinomas","volume":"40","author":"Howell","year":"2003","journal-title":"J Med Genet"},{"key":"2024013021125003600_bib23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s002689900567","article-title":"Evaluation of retinoblastoma and Ki-67 immunostaining as diagnostic markers of benign and malignant parathyroid disease","volume":"23","author":"Farnebo","year":"1999","journal-title":"World J Surg"},{"key":"2024013021125003600_bib24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/978-3-642-59655-1","volume-title":"World Health Organization International Histological Classification of Tumours. Histological Typing of Endocrine Tumours","author":"Solcia","year":"2000","edition":"2nd ed."},{"key":"2024013021125003600_bib25","first-page":"124","volume-title":"Endocrine Pathology","author":"Apel","year":"2002"},{"key":"2024013021125003600_bib26","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/00000478-199308000-00007","article-title":"Histopathological variables and DNA cytometry in parathyroid carcinoma","volume":"17","author":"Bondeson","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"2024013021125003600_bib27","first-page":"495","article-title":"Pathology of the parathyroids in hyperparathyroidism","volume":"73","author":"Roth","year":"1962","journal-title":"Arch Pathol"},{"key":"2024013021125003600_bib28","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/1097-0142(197303)31:3<600::AID-CNCR2820310316>3.0.CO;2-0","article-title":"Parathyroid carcinoma: A study of 70 cases","volume":"31","author":"Schantz","year":"1973","journal-title":"Cancer"},{"key":"2024013021125003600_bib29","first-page":"882","article-title":"Parathyroid carcinoma: Diagnosis and clinical history","volume":"114","author":"Vetto","year":"1993","journal-title":"Surgery"},{"key":"2024013021125003600_bib30","first-page":"978","article-title":"Metastatic parathyroid carcinoma: Dilemma in the management","volume":"110","author":"Sandelin","year":"1991","journal-title":"Surgery"},{"key":"2024013021125003600_bib31","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/BF02067369","article-title":"Prognostic factors in parathyroid cancer: A review of 95 cases","volume":"16","author":"Sandelin","year":"1992","journal-title":"World J Surg"},{"key":"2024013021125003600_bib32","first-page":"906","article-title":"Parathyroid carcinomas: Features and difficulties in diagnosis and management","volume":"94","author":"Anderson","year":"1983","journal-title":"Surgery"},{"key":"2024013021125003600_bib33","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0002-9343(94)90312-3","article-title":"Parathyroid carcinoma arising from parathyroid hyperplasia: Autoinfarction following intravenous treatment with pamidronate","volume":"97","author":"de Papp","year":"1994","journal-title":"Am J Med"},{"key":"2024013021125003600_bib34","first-page":"1378","article-title":"Nocturnal hyperparathyroidism: A frequent feature of X-linked hypophosphatemia","volume":"78","author":"Carpenter","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013021125003600_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2796.2004.01428.x","article-title":"Parathyroid surgery in familial hyperparathyroid disorders","volume":"257","author":"Carling","year":"2005","journal-title":"J Intern Med"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2Fjbmr.060702","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/21\/10\/1666\/56483011\/5650211019.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/21\/10\/1666\/56483011\/5650211019.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:47:15Z","timestamp":1710341235000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/21\/10\/1666-1671\/7593227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,1]]},"references-count":35,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2009,12,4]]},"published-print":{"date-parts":[[2006,10,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.060702","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2006,10,1]]},"published":{"date-parts":[[2006,10,1]]}}}